CTEPH DIAGNOSIS Europe - MRI

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1080 participants.

Also called NCT02791282

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 1,080 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02791282
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02791282. Allocation not applicable; no masking; primary purpose diagnostic. Start 2016-05 (registry gives no type); primary completion 2020-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CTEPH DIAGNOSIS Europe - MRI
Intervention (Other)
Index test: functional dynamic contrast enhanced (DCE)-MRI
Lead sponsor
Hannover Medical School (class: other)
Collaborator
University of Sheffield (class: other)
Collaborator
University of Giessen (class: other)
Collaborator
Ludwig-Maximilians - University of Munich (class: other)
Collaborator
Heidelberg University (class: other)

Record details

Record id
cardio:ct-nct02791282
Content hash
be7f2363d78797ca965308812d756fa6e2cdf9cb178660f362183140c5f2ec7f